Phenyl-(1,2,4)-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals

Details for Australian Patent Application No. 2006299092 (hide)

Owner Sanofi-Aventis

Inventors Urmann, Matthias; Glien, Maike; Keil, Stefanie; Wendler, Wolfgang; Bernardelli, Patrick; Lee, Lan; Chandross, Karen; Matter, Hans

Agent Watermark

Pub. Number AU-A-2006299092

PCT Pub. Number WO2007/039178

Priority 05021235.6 29.09.05 EP

Filing date 26 September 2006

Wipo publication date 12 April 2007

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039178 Priority application(s): WO2007/039178

7 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299097-Sythesis of renin inhibitors involving a cycloaddition reaction

2006299091-Phenyland pyridinyl1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals